Lamotrigine
Product Images NDC 58118-1111

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 58118-1111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (1f54285f 566c 4e96 867e 4e8dfdd3340a 01)

Molecular Structure (1f54285f 566c 4e96 867e 4e8dfdd3340a 01)
Chemical structure diagram of the active ingredient lamotrigine, showing its molecular arrangement including chlorine atoms, amino groups, and a triazine ring.*
FDA Label Image

Figure 1 (1f54285f 566c 4e96 867e 4e8dfdd3340a 02)

Figure 1 (1f54285f 566c 4e96 867e 4e8dfdd3340a 02)
A Kaplan-Meier survival curve comparing failure probability (%) over weeks for Lamotrigine versus Placebo. The graph shows two lines indicating the failure probabilities for each group over a period of up to 100 weeks, with censored data points marked. Lamotrigine has a lower failure probability compared to Placebo throughout the timeline.*
FDA Label Image

Figure 2 (1f54285f 566c 4e96 867e 4e8dfdd3340a 03)

Figure 2 (1f54285f 566c 4e96 867e 4e8dfdd3340a 03)
A Kaplan-Meier failure probability plot comparing Placebo and Lamotrigine groups over approximately 80 weeks. The vertical axis represents failure probability percentage, and the horizontal axis shows time in weeks. The graph includes markers for censored data points.*
FDA Label Image

Tablet Pictorial View (1f54285f 566c 4e96 867e 4e8dfdd3340a 04)

Tablet Pictorial View (1f54285f 566c 4e96 867e 4e8dfdd3340a 04)
The image shows four sets of Lamotrigine tablets in various strengths, each with a white or light blue color. The 25 mg tablets are white and oval-shaped with the imprint '111'. The 100 mg tablets are white and triangular with the imprint '112'. The 150 mg tablets are white and triangular with the imprint '113'. The 200 mg tablets are light blue and pill-shaped with the imprint '114'. Tablets have the letter 'U' prominently embossed.*
FDA Label Image

Logo (1f54285f 566c 4e96 867e 4e8dfdd3340a 05)

FDA Label Image

Lamot 25

Lamot 25
Packaging label for Lamotrigine 25mg Tablets by Clinical Solutions Wholesale. The label shows the product name and strength clearly with an NDC of 58118-1111-8 and a quantity of 30 tablets. The label includes manufacturing details by Unichem Pharmaceuticals in Hasbrouck Heights, NJ, USA, and repackaging information from Clinical Solutions Wholesale in Franklin, TN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.